Company
Peptilogics
Peptilogics is a surgical therapeutics company advancing a novel anti-biofilm drug designed to cure and prevent all medical device-related infections.
Also known as Peptilogics, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- Peptilogics, Inc.
- peptilogics.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Peptilogics, a clinical-stage biotechnology platform company that is focused on developing novel peptide therapeutics using its proprietary computational platform.
Funding snapshot
- Total raised
- $40.9MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $35.8M2020-12-15
Funding rounds
- Round, 2020
- $35.8M2020-12-15, SEC form D sold, 19 investors
- Round, 2017
- $4M2017-08-18, SEC form D sold, 1 investor
- Round, 2017
- $754K2017-05-02, SEC form D sold, 7 investors
- Round, 2016
- $417K2016-01-08, SEC form D sold, 2 investors
Loading relationship preview